C. Willemien Menke‐van der Houven van Oordt

Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis

Hanke L. Matlung, Liane Babes, Xi Zhao et al. · Cell Reports · 2018 · 372 citations · Full text

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Géraldine Gebhart, Laetitia E. Lamberts, Zéna Wimana et al. · Annals of Oncology · 2015 · 341 citations · Full text

Breast Oncology, Oncology, Engineering +13

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study

Anouk H. Eijkelboom, Linda de Munck, Marie-Jeanne T. F. D. Vrancken Peeters et al. · Journal of Hematology & Oncology · 2021 · 152 citations · Full text

First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors

C. Willemien Menke‐van der Houven van Oordt, Carlos Gomez-Roca, Carla van Herpen et al. · Oncotarget · 2016 · 148 citations · Full text

89Zr-cetuximab PET imaging in patients with advanced colorectal cancer

C. Willemien Menke‐van der Houven van Oordt, Elske C. Gootjes, Marc C. Huisman et al. · Oncotarget · 2015 · 126 citations · Full text